v3.23.2

Stockholders' Equity - Noncontrolling Interest (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($) Vote shares	Dec. 31, 2022 USD ($) $ / shares	Jun. 30, 2023 USD ($) Vote shares	Oct. 31, 2022
Stockholders' Equity
Proceeds from issuance of warrants and shares			$ 934,480
Duet Private Placement
Stockholders' Equity
Proceeds from issuance of warrants and shares		$ 276,065
Additional proceeds from issuance of warrants and shares	$ 6,762		1,096,365
Issuance costs	20		84,092
Stock subscription receivable	$ 5,962	$ 33,950	5,962
Offering price (per share) \| $ / shares		$ 2.50
Duet
Stockholders' Equity
Proceeds from issuance of warrants and shares		$ 276,065
Amount allocated to non-controlling interest			$ (12,812)
Percentage of financial interest held	98.00%		98.00%	90.00%
Duet \| Exchange agreement
Stockholders' Equity
Number of additional shares of capital stock authorized \| shares			50,000,000
Duet \| Exchange agreement \| Class B Common Stock
Stockholders' Equity
Number of votes per share \| Vote	1		1
Number of shares issued per unit / share \| shares	1		1
Duet \| Exchange agreement \| Class A Common Stock
Stockholders' Equity
Number of votes per share \| Vote	10		10
Number of shares issued per unit / share \| shares	1		1
Duet \| Duet
Stockholders' Equity
Amount allocated to non-controlling interest	$ 22,416

The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.

+ References

No definition available.

+ Details

Name:	scps_AdditionalProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix:	scps_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

The amount of increase (decrease) in non-controlling interest due to the change in ownership of Duet and as a result of the proceeds received in connection with the Duet Private Placement.

+ References

No definition available.

+ Details

Name:	scps_AmountAllocatedToNonControllingInterest
Namespace Prefix:	scps_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Number of additional shares authorized for capital stock.

+ References

No definition available.

+ Details

Name:	scps_CapitalStockAdditionalSharesAuthorized
Namespace Prefix:	scps_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Number of shares into which each share is converted.

+ References

No definition available.

+ Details

Name:	scps_NumberOfSharesIntoWhichEachShareIsConverted
Namespace Prefix:	scps_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

The number of votes per share.

+ References

No definition available.

+ Details

Name:	scps_NumberOfVotesPerShare
Namespace Prefix:	scps_
Data Type:	xbrli:integerItemType
Balance Type:	na
Period Type:	instant

- Definition

Amount of stock subscription receivable, classified as current as on the balance sheet date.

+ References

No definition available.

+ Details

Name:	scps_StockSubscriptionReceivableCurrent
Namespace Prefix:	scps_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_ClassOfWarrantOrRightLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The parent entity's interest in net assets of the subsidiary, expressed as a percentage.

+ References

No definition available.

+ Details

Name:	us-gaap_MinorityInterestOwnershipPercentageByParent
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant

- Definition

The cash outflow for cost incurred directly with the issuance of an equity security.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-15

+ Details

Name:	us-gaap_PaymentsOfStockIssuanceCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 45
-Paragraph 14
-Subparagraph (a)
-SubTopic 10
-Topic 230
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147482740/230-10-45-14

+ Details

Name:	us-gaap_ProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.

+ References

No definition available.

+ Details

Name:	us-gaap_SaleOfStockPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_SubsidiarySaleOfStockAxis=scps_DuetPrivatePlacementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_OwnershipAxis=scps_DuetTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=us-gaap_CapitalSupportAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=scps_DuetTherapeuticsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Scopus BioPharma Inc. 10-Q